Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
94.19 EGP | 0.00% | 0.00% | +35.27% |
Kurzporträt
Mitarbeiterzahl: 1 148
Umsatz nach Geschäftsbereich
EGP in Millionen | 2022 | Gewichtung | Delta |
---|---|---|---|
Pharmaceutical and Chemical Products
100,0
%
| 505 | 100,0 % | - |
Umsatz je Region
EGP in Millionen | 2022 | Gewichtung | Delta |
---|---|---|---|
Egypt
100,0
%
| 505 | 100,0 % | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Executive Officer | - | - | |
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Human Resources Officer | - | - | |
Sales & Marketing | - | - | |
Corporate Secretary | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Investor Relations Contact | - | - | |
Chief Executive Officer | - | - | |
Chairman | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | 30.09.21 | |
Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 6 000 000 | 1 508 719 ( 25,15 %) | 0 | 25,15 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+35.27% | 12.12 Mio. | |
+37.96% | 705 Mrd. | |
+32.82% | 583 Mrd. | |
-3.59% | 364 Mrd. | |
+20.16% | 332 Mrd. | |
+5.25% | 291 Mrd. | |
+17.13% | 238 Mrd. | |
-3.68% | 210 Mrd. | |
+10.51% | 209 Mrd. | |
+8.39% | 169 Mrd. |
- Börse
- Aktien
- ADCI Aktie
- Unternehmen The Arab Drug Company